DE602004027401D1 - Verfahren zur herstellung von polymorphen von sertralin hydrochlorid - Google Patents

Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Info

Publication number
DE602004027401D1
DE602004027401D1 DE602004027401T DE602004027401T DE602004027401D1 DE 602004027401 D1 DE602004027401 D1 DE 602004027401D1 DE 602004027401 T DE602004027401 T DE 602004027401T DE 602004027401 T DE602004027401 T DE 602004027401T DE 602004027401 D1 DE602004027401 D1 DE 602004027401D1
Authority
DE
Germany
Prior art keywords
polymorphes
preparing
sertraline hydrochloride
sertraline
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027401T
Other languages
English (en)
Inventor
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of DE602004027401D1 publication Critical patent/DE602004027401D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004027401T 2003-11-04 2004-11-04 Verfahren zur herstellung von polymorphen von sertralin hydrochlorid Active DE602004027401D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1158MU2003 2003-11-04
PCT/GB2004/004672 WO2005047229A2 (en) 2003-11-04 2004-11-04 Process for the preparation of polymorphs of selective serotonin reuptake inhibitor

Publications (1)

Publication Number Publication Date
DE602004027401D1 true DE602004027401D1 (de) 2010-07-08

Family

ID=34586963

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027401T Active DE602004027401D1 (de) 2003-11-04 2004-11-04 Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Country Status (13)

Country Link
US (1) US7893300B2 (de)
EP (1) EP1682483B1 (de)
JP (1) JP4791970B2 (de)
KR (1) KR101161813B1 (de)
CN (1) CN1902157A (de)
AT (1) ATE469119T1 (de)
AU (1) AU2004289512A1 (de)
CA (1) CA2544684A1 (de)
DE (1) DE602004027401D1 (de)
NZ (1) NZ546902A (de)
RU (1) RU2376279C2 (de)
WO (1) WO2005047229A2 (de)
ZA (1) ZA200603502B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2984109B1 (de) * 2013-06-04 2019-09-25 Dow Global Technologies LLC Verfahren zur herstellung von lithiumcarboxymethylcellulose
CN112552188B (zh) * 2020-12-17 2023-07-28 山西仟源医药集团股份有限公司 盐酸舍曲林晶型i的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
BR9810403A (pt) * 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) * 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
IL150332A0 (en) * 1999-12-21 2002-12-01 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
EP1499581A1 (de) 2002-04-29 2005-01-26 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung der polymorphen form ii von sertralinhydrochlorid, pharmazeutische formulierungen und verfahren zur deren verabreichung

Also Published As

Publication number Publication date
ATE469119T1 (de) 2010-06-15
ZA200603502B (en) 2008-02-27
CN1902157A (zh) 2007-01-24
KR101161813B1 (ko) 2012-07-05
US20070135524A1 (en) 2007-06-14
RU2376279C2 (ru) 2009-12-20
AU2004289512A2 (en) 2005-05-26
JP2007510640A (ja) 2007-04-26
RU2006119477A (ru) 2007-12-20
US7893300B2 (en) 2011-02-22
JP4791970B2 (ja) 2011-10-12
KR20060123234A (ko) 2006-12-01
EP1682483B1 (de) 2010-05-26
CA2544684A1 (en) 2005-05-26
EP1682483A2 (de) 2006-07-26
NZ546902A (en) 2010-02-26
AU2004289512A1 (en) 2005-05-26
WO2005047229A2 (en) 2005-05-26
WO2005047229A3 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
DE602004031895D1 (de) Verfahren zur Herstellung von Dichlorpropanol
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE602004010234D1 (de) Verfahren zur herstellung von 4-aminodiphenylamin
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
DE602004027401D1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
DE502004011536D1 (de) verfahren zur herstellung von bengamide-derivaten
DE602004025752D1 (de) Verfahren zur herstellung von 4,4,4-trifluorbutan-2-on
DE502004005103D1 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten
DE602004018447D1 (de) Verfahren zur Herstellung von Alkylbenzaldehyden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition